Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Genome Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The genome testing market is experiencing ...

このミニコースでは、微生物のゲノム配列とアノテーションにどのようにアクセスし、 どのようにデータを見ればよいか、また遺伝子やアミノ酸配列情報をどのようにダウンロードすればよいかを 紹介すると共に、NCBIから提供されている個別ゲノムや比較 ...

GeneDx’s exome and genome testing revenue, which represents its core business, jumped 69% YoY to $85.9 million. "Crossing the $100 million revenue mark and delivering our fourth consecutive profitable ...

GeneDx Recognizes Cerebral Palsy Awareness Month with Commitment to Improve Access to Testing GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes ...

STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a new way to provide genetic counseling and ...

ultraRapid testing addresses the underutilization of testing in the NICU and can lead to more than $15K in healthcare savings per child GAITHERSBURG, Md., February 13, 2025--(BUSINESS WIRE)--GeneDx ...

New Delhi: Fortis Hospital's diagnostics arm, Agilus Diagnostics, has launched a genome test designed to detect cancer with a three-day turnaround time (TAT) for test results in myeloid malignancies.

A national study in Israel demonstrates the feasibility and diagnostic benefits of rapid trio genome sequencing in critically ill neonates. Researchers conducted a prospective, multicenter cohort ...

Editor's Note: This interview is part of an ongoing Star series highlighting Kansas Citians from historically underrepresented communities and their impact on our region. The series builds on The Star ...

GC Biopharma's liquid biopsy and genomic analysis subsidiary, GC Genome, announced on the 27th that it has signed a supply contract for the non-invasive prenatal test 'G-NIPT' with Vollwert Medical ...